Zacks Research Has Optimistic Outlook of Integer Q4 Earnings

Integer Holdings Co. (NYSE:ITGR - Free Report) - Equities researchers at Zacks Research lifted their Q4 2024 earnings per share estimates for shares of Integer in a report issued on Tuesday, January 7th. Zacks Research analyst D. Dey now expects that the medical equipment provider will earn $1.46 per share for the quarter, up from their prior estimate of $1.45. The consensus estimate for Integer's current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Integer's Q3 2026 earnings at $1.65 EPS.

Several other analysts have also recently weighed in on ITGR. Benchmark raised their price target on Integer from $130.00 to $140.00 and gave the company a "buy" rating in a report on Monday, October 21st. Citigroup lifted their target price on shares of Integer from $130.00 to $145.00 and gave the company a "neutral" rating in a research report on Wednesday, December 11th. KeyCorp increased their price target on shares of Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a report on Tuesday, October 15th. Bank of America lifted their price objective on shares of Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a report on Tuesday, October 1st. Finally, Truist Financial increased their target price on Integer from $147.00 to $163.00 and gave the company a "buy" rating in a research note on Wednesday, December 11th. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $145.44.

Integer Price Performance

Shares of ITGR stock traded up $0.71 on Friday, reaching $133.83. The company's stock had a trading volume of 253,611 shares, compared to its average volume of 152,419. The company has a market capitalization of $4.49 billion, a P/E ratio of 41.31, a PEG ratio of 1.99 and a beta of 1.12. Integer has a 12-month low of $94.56 and a 12-month high of $142.76. The stock's 50 day simple moving average is $135.73 and its 200-day simple moving average is $127.72. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The company had revenue of $431.42 million during the quarter, compared to analysts' expectations of $440.59 million. During the same quarter in the previous year, the company earned $1.27 earnings per share. Integer's revenue for the quarter was up 8.7% on a year-over-year basis.

Hedge Funds Weigh In On Integer

Large investors have recently bought and sold shares of the stock. Driehaus Capital Management LLC increased its stake in shares of Integer by 62.5% in the second quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider's stock worth $40,880,000 after buying an additional 135,750 shares during the period. Eagle Asset Management Inc. purchased a new position in shares of Integer in the third quarter valued at about $14,403,000. Point72 Europe London LLP bought a new position in shares of Integer during the second quarter valued at about $6,241,000. Bamco Inc. NY raised its stake in shares of Integer by 17.4% during the third quarter. Bamco Inc. NY now owns 254,377 shares of the medical equipment provider's stock valued at $33,069,000 after acquiring an additional 37,700 shares during the last quarter. Finally, Earnest Partners LLC boosted its holdings in shares of Integer by 3.2% during the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider's stock worth $139,911,000 after purchasing an additional 37,340 shares during the period. 99.29% of the stock is owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.